中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
首页 机构 成果 学者
  
  1. CAS IR Grid
机构
采集方式
内容类型
发表日期
学科主题
筛选

浏览/检索结果: 共117条，第1-10条 帮助

条数/页： 排序方式：
Vegetation structural shift tells environmental changes on the Tibetan Plateau over 40 years 期刊论文  OAI收割
SCIENCE BULLETIN, 2023, 卷号: 68, 期号: 17, 页码: 1928-1937
作者:  Wang, Yanfen;  Xue, Kai;  Hu, Ronghai;  Ding, Boyang;  Zeng, Hong
  |  收藏  |  浏览/下载：33/0  |  提交时间：2023/10/30
Vegetation structural shift tells environmental changes on the Tibetan Plateau over 40 years 期刊论文  OAI收割
SCIENCE BULLETIN, 2023, 卷号: 68, 期号: 17, 页码: 1928
作者:  Wang, Yanfen;  Xue, Kai;  Hu, Ronghai;  Ding, Boyang;  Zeng, Hong
  |  收藏  |  浏览/下载：35/0  |  提交时间：2023/12/01
Efficacy and safety of niraparib as maintenance treatment in patients with newly diagnosed advanced ovarian cancer using an individualized starting dose (PRIME Study): A randomized, double-blind, placebo-controlled, phase 3 trial 期刊论文  OAI收割
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2022, 卷号: 18
作者:  Li, Ning;  Zhu, Jianqing;  Yin, Rutie;  Wang, Jing;  Pan, Lingya
  |  收藏  |  浏览/下载：40/0  |  提交时间：2022/12/23
Carbon and nitrogen cycling on the Qinghai-Tibetan Plateau 期刊论文  OAI收割
Nature Reviews Earth & Environment, 2022, 卷号: 3, 期号: 10, 页码: 701-716
作者:  Huai Chen;  Peijun Ju;  Qiuan Zhu;  Xingliang Xu;  Ning Wu
  |  收藏  |  浏览/下载：60/0  |  提交时间：2022/10/25
Fuzuloparib Maintenance Therapy in Patients With Platinum-Sensitive, Recurrent Ovarian Carcinoma (FZOCUS-2): A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase III Trial 期刊论文  OAI收割
JOURNAL OF CLINICAL ONCOLOGY, 2022, 卷号: 40
作者:  Li, Ning;  Zhang, Youzhong;  Wang, Jing;  Zhu, Jianqing;  Wang, Li
  |  收藏  |  浏览/下载：117/0  |  提交时间：2022/12/22
An Efficient Multiresolution Network for Vehicle Reidentification 期刊论文  OAI收割
IEEE INTERNET OF THINGS JOURNAL, 2022, 卷号: 9, 期号: 11, 页码: 9049-9059
作者:  Shen, Fei;  Zhu, Jianqing;  Zhu, Xiaobin;  Huang, Jingchang;  Zeng, Huanqiang
  |  收藏  |  浏览/下载：44/0  |  提交时间：2022/07/25
Efficacy of niraparib maintenance therapy in patients with newly diagnosed advanced ovarian cancer in phase 3 PRIME study: A subgroup analysis by response to first-line platinum-based chemotherapy. 期刊论文  OAI收割
JOURNAL OF CLINICAL ONCOLOGY, 2022, 卷号: 40
作者:  Yin, Rutie;  Li, Ning;  Wu, Lingying;  Wang, Jing;  Zhu, Jianqing
  |  收藏  |  浏览/下载：33/0  |  提交时间：2022/12/23
Exploratory hrd and PD-L1 analysis of l-MOCA study: Olaparib maintenance monotherapy in Asian patients with platinum-sensitive relapsed ovarian cancer. 期刊论文  OAI收割
JOURNAL OF CLINICAL ONCOLOGY, 2022, 卷号: 40
作者:  Ma, Ding;  Gao, Qing-Lei;  Zhu, Jianqing;  Zhao, Weidong;  Huang, Yi
  |  收藏  |  浏览/下载：43/0  |  提交时间：2022/12/23
Olaparib maintenance monotherapy in Chinese patients with platinum-sensitive relapsed ovarian cancer: China cohort from the phase III SOLO2 trial 期刊论文  OAI收割
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2022
作者:  Liu, Jihong;  Yin, Rutie;  Wu, Lingying;  Zhu, Jianqing;  Lou, Ge
  |  收藏  |  浏览/下载：70/0  |  提交时间：2022/05/05
Pamiparib Monotherapy for Patients with Germline BRCA1/2-Mutated Ovarian Cancer Previously Treated with at Least Two Lines of Chemotherapy: A Multicenter, Open-Label, Phase II Study 期刊论文  OAI收割
CLINICAL CANCER RESEARCH, 2022, 卷号: 28
作者:  Wu, Xiaohua;  Zhu, Jianqing;  Wang, Jing;  Lin, Zhongqiu;  Yin, Rutie
  |  收藏  |  浏览/下载：79/0  |  提交时间：2022/03/28